Advertisement

Picture Swiss Biotech Association LSUS Global Village 2025 Basel 650x100px
Organisation › Details

T-Curx GmbH

T-CURX is a privately owned, German Biotech company based in Würzburg founded in 2017 with the vision of bringing next-generation CAR-T cell therapies manufactured with more cost-effective and highly scalable CAR-T cell technologies to more cancer patients in need of more effective cancer therapies. The proprietary CAR-T technologies of T-CURX were developed in the laboratory of co-founder Prof. Michael Hudecek at the University of Würzburg and are exclusively licensed to T-CURX. The highly efficient, scalable and cost-effective core technology is based on virus-free, Sleeping-beauty transposon gene transfer into patient’s T cells. Additional proprietary technologies that will be leveraged in T-CURX’ developing CAR-T cell product pipeline include (i) the proprietary Matchmaker technology for optimized potency and efficacy of T-CURX’ CAR-T cell products and (ii) a proprietary safety-switch that allows controlling the function of CAR-T cells after infusion into patients to improve the patient safety. *

 

Period Start 2017-03-06 established (s-off)
  Predecessor University Hospital Würzburg (Universitätsklinikum Würzburg)
Products Industry cancer immunotherapy (immuno-oncology, I-O)
  Industry 2 Sleeping Beauty transposon technology for gene editing
Persons Person Grawunder, Ulf (T-Curx 202210– CEO + Co-Founder before NBE Therapeutics + 4-Antibody)
  Person 2 Jung, Marion (T-Curx 202402– COO before ChromoTek Managing Director + Co-Founder + Earlybird Ventures)
     
Region Region Würzburg
  Country Germany
  Street 15 Friedrich-Bergius-Ring
Innovations- und Gründerzentrum Würzburg
  City 97076 Würzburg
  Tel +49-931-25099712
    Address record changed: 2024-02-11
     
Basic data Employees n. a.
     
    * Document for »About Section«: T-Curx GmbH. (10/6/22). "Press Release: T-Curx GmbH, a German CAR-T Cell Biotech Spin-Off from University of Würzburg, Appoints Ulf Grawunder as CEO". Würzburg.
     
   
Record changed: 2024-12-29

Advertisement

Picture Swiss Biotech Association LSUS Swiss Biotech Days 2025 Basel 650x200px

More documents for T-Curx GmbH


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association LSUS Swiss Biotech Days 2025 Basel 650x300px




» top